Malaysia's central bank left its key benchmark interest rate unchanged on Wednesday, bucking expectations it would provide further monetary support to an economy facing fresh lockdowns amid surging coronavirus cases.
Malaysia will introduce 15 billion ringgit ($3.71 billion) worth of additional stimulus measures to support its pandemic-hit economy and fight COVID-19, Prime Minister Muhyiddin Yassin said on Monday.
A Pakistan International Airlines plane has been held back by Malaysian authorities due to a British court case over the jet's lease, the airline said on Friday, adding it would pursue the matter through diplomatic channels.
Malaysia's opposition leader Anwar Ibrahim said on Thursday he would submit an appeal to the king to end a state of emergency imposed to fight the coronavirus, which he described as a move by the prime minister to cling to power.
Had reported 78% efficacy in mild-to-severe cases Chairman says results are good around the world Malaysia and Singapore seeking more data (Recasts to add details from Sinovac executive, Thailand and Singapore, and background)
KUALA LUMPUR/SINGAPORE, Jan 13 (Reuters) - China’s Sinovac Biotech defended the safety and efficacy of its experimental COVID-19 vaccine on Wednesday, after researchers in Brazil released late-stage clinical data showing efficacy that was much lower than initially announced.
The vaccine was just 50.4% effective at preventing symptomatic infections in the Brazilian trial, including data on “very mild” cases, researchers said on Tuesday.
Last week, they said the vaccine, called CoronaVac, showed 78% efficacy against “mild-to-severe” cases.